MiMedx Group MDXG Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $58.99M-33.1% | $118.1M+27.1% | $113.73M+35.3% | $98.61M+13.1% | $88.21M+4.1% | ||
| $17.37M+4.9% | $19.06M+12.7% | $18.72M+22.2% | $18.68M+25.8% | $16.56M+27.5% | ||
| $41.62M-41.9% | $99.04M+30.3% | $95.01M+38.2% | $79.92M+10.5% | $71.65M-0.1% | ||
| 70.6%-10.7pp | 83.9%+2.1pp | 83.5%+1.8pp | 81.1%-1.9pp | 81.2%-3.4pp | ||
| $4.14M+24.4% | $4.76M+33.3% | $3.7M+26.9% | $3.3M+9.7% | $3.33M+17.1% | ||
| $53.23M-11.2% | $73.07M+19.7% | $69M+28.9% | $64.15M+15.8% | $59.97M+8.8% | ||
| $301K+204% | $129K-33.2% | $112K-41.7% | $100K-47.4% | $99K-47.6% | ||
| -$16.05M-295% | $21.08M+90.7% | $22.19M+98.8% | $12.37M-47.2% | $8.25M-37.5% | ||
| -27.2%-36.6pp | 17.8%+5.9pp | 19.5%+6.2pp | 12.5%-14.3pp | 9.4%-6.2pp | ||
| $886K+75.1% | $904K— | $785K+182% | $738K+24,500% | $506K+130% | ||
| -$168K-15.9% | -$186K+10.6% | -$126K-500% | -$101K+57.4% | -$145K-46.5% | ||
| -$15.33M-278% | $21.8M+93.8% | $22.85M+100% | $13.01M-44.0% | $8.61M-24.5% | ||
| -$4.47M-381% | $6.6M+73.3% | $6.1M+72.3% | $3.39M-39.4% | $1.59M-32.3% | ||
| -$0.07-240% | $0.10+100.0% | $0.11+120% | $0.06-50.0% | $0.05-16.7% | ||
| -$0.07-240% | $0.10+100% | $0.11+120% | $0.07-41.7% | $0.05-16.7% | ||
| 148.4M-0.8% | 149.7M+0.5% | 149.7M+0.9% | 149.3M+0.3% | 149.7M-0.2% | ||
| 148.4M+0.8% | 147.8M+0.6% | 148M+0.7% | 147.8M+0.3% | 147.3M+0.6% | ||
| —— | $0+100% | $0+100% | $0+100% | $0+100% | ||
| $886K+75.1% | $904K— | $785K+182% | $738K+24,500% | $506K+130% | ||
| -$10.86M-255% | $15.19M+104% | $16.75M+113% | $9.62M-45.4% | $7.02M-22.5% | ||
| -$168K-15.9% | -$186K+10.6% | -$126K-500% | -$101K+57.4% | -$145K-46.5% | ||
| $58.99M-33.1% | $118.1M+27.1% | $113.73M+35.3% | $98.61M+13.1% | $88.21M+4.1% | ||
| -$16.05M-295% | $21.08M+90.7% | $22.19M+98.8% | $12.37M-47.2% | $8.25M-37.5% | ||
| -$15.75M-232% | $24.8M+97.4% | $25.91M+104% | $16.09M-35.5% | $11.97M-18.6% | ||
| -$15.75M-232% | $24.8M+97.4% | $25.91M+104% | $16.09M-35.5% | $11.97M-18.6% | ||
| -26.7%-40.3pp | 21%+7.5pp | 22.8%+7.7pp | 16.3%-12.3pp | 13.6%-3.8pp | ||
| -$16.05M-295% | $21.08M+90.7% | $22.19M+98.8% | $12.37M-47.2% | $8.25M-37.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is MiMedx Group's revenue?
- MiMedx Group (MDXG) generated $389.4M in revenue over the trailing twelve months, up 10.5% year over year.
- Is MiMedx Group profitable?
- MiMedx Group reported $30.7M in net income over the trailing twelve months, a 7.9% net margin.
- What are MiMedx Group's profit margins?
- Gross margin is 81.0% and operating margin is 10.2%, with a 7.9% net margin.
- What is MiMedx Group's earnings per share?
- MiMedx Group's diluted EPS over the trailing twelve months is $0.20.
- Where does MiMedx Group's income statement data come from?
- Every line is extracted from MiMedx Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
